<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05101512</url>
  </required_header>
  <id_info>
    <org_study_id>2018-A02444-51</org_study_id>
    <nct_id>NCT05101512</nct_id>
  </id_info>
  <brief_title>Assessment of the Sub-gonal Arterial Revascularization of the Lower Limbs in Critical Ischemia by Venous Allograft Stored at + 4 ° C (ERAV)</brief_title>
  <acronym>ERAV</acronym>
  <official_title>Assessment of the Sub-gonal Arterial Revascularization of the Lower Limbs in Critical Ischemia by Venous Allograft Stored at + 4 ° C.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ramsay Générale de Santé</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>European Clinical Trial Experts Network</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Private Hospital Dijon</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Ramsay Générale de Santé</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main objective of this study is to assess the 2-year survival with salvage of the lower&#xD;
      limb of patients who have undergone subgonal bypass grafting by venous allograft in the&#xD;
      treatment of Occlusive Peripheral Arterial Disease (OPAD) in critical ischemia, in the&#xD;
      absence of usable great saphenous vein.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2020</start_date>
  <completion_date type="Anticipated">January 15, 2024</completion_date>
  <primary_completion_date type="Anticipated">July 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Survival rate of patients at 2 years with lower limb rescue</measure>
    <time_frame>2 years</time_frame>
    <description>survival rate of patients at 2 years with lower limb rescue (time until death or amputation - amputation free survival)</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Venous Allogeneic Transplant</condition>
  <condition>Occlusive Peripheral Arterial Disease</condition>
  <arm_group>
    <arm_group_label>Patient with critical ischemia of the lower limb</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patient eligible and scheduled for bypass in venous allograft stored at + 4 ° C with distal anastomosis below the knee</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Questionnaires on quality of life after surgery</intervention_name>
    <description>Patient has to answer different questionnaire about quality of life, pain, functional scores</description>
    <arm_group_label>Patient with critical ischemia of the lower limb</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Man or woman over 18 (under effective contraception, hormonal contraceptive or&#xD;
             intrauterine device, if premenopausal).&#xD;
&#xD;
          -  Patient with critical ischemia of the lower limb (stage 4-5-6 according to the&#xD;
             Rutherford classification) requiring revascularization by sub-gonal bypass&#xD;
&#xD;
          -  Patient eligible and scheduled for bypass in venous allograft stored at + 4 ° C with&#xD;
             distal anastomosis below the knee&#xD;
&#xD;
          -  Patient without usable autologous great Saphenous vein&#xD;
&#xD;
          -  Subject affiliated or beneficiary of a social security scheme&#xD;
&#xD;
          -  Patient having received the appropriate information concerning the objectives and&#xD;
             procedures of the study and having declared his non-objection.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Use of unscheduled allografts&#xD;
&#xD;
          -  Patient requiring composite bypass in AGV + autologous venous material or prosthesis&#xD;
&#xD;
          -  Patient requiring replacement of infected prostheses&#xD;
&#xD;
          -  Patient with acute ischemia&#xD;
&#xD;
          -  Patient with severe coagulation disorders&#xD;
&#xD;
          -  Patient classified physical status score 4&#xD;
&#xD;
          -  Patient participating in another clinical trial&#xD;
&#xD;
          -  Potential allergy to the graft&#xD;
&#xD;
          -  Protected patients: Adults under guardianship, curatorship or other legal protection,&#xD;
             deprived of their liberty by judicial or administrative decision&#xD;
&#xD;
          -  Pregnant or breastfeeding woman&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jean-François Oudet</last_name>
    <phone>0683346567</phone>
    <email>jf.oudet@ecten.eu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Marie-Hélène Barba</last_name>
    <email>mh.barba@ecten.eu</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Private Hospital of Dijon</name>
      <address>
        <city>Dijon</city>
        <zip>21000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jea-Luc Pin, Dr</last_name>
      <phone>06 77 14 84 45</phone>
      <email>jeanlucpin@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 28, 2021</study_first_submitted>
  <study_first_submitted_qc>October 28, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2021</study_first_posted>
  <last_update_submitted>October 28, 2021</last_update_submitted>
  <last_update_submitted_qc>October 28, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Peripheral Arterial Disease</mesh_term>
    <mesh_term>Peripheral Vascular Diseases</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

